Growing community of inventors

Medford, MA, United States of America

Anthony C Arvanites

Average Co-Inventor Count = 6.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Anthony C Arvanites ↔ Richard B Silverman (5 patents)Anthony C Arvanites ↔ Richard I Morimoto (5 patents)Anthony C Arvanites ↔ Radhia Benmohamed (5 patents)Anthony C Arvanites ↔ Donald R Kirsch (5 patents)Anthony C Arvanites ↔ Wei Zhang (3 patents)Anthony C Arvanites ↔ Tian Chen (1 patent)Anthony C Arvanites ↔ Guoyao Xia (1 patent)Anthony C Arvanites ↔ Tian Chen (1 patent)Anthony C ArvanitesAnthony C Arvanites (5 patents)Richard B SilvermanRichard B Silverman (107 patents)Richard I MorimotoRichard I Morimoto (7 patents)Radhia BenmohamedRadhia Benmohamed (5 patents)Donald R KirschDonald R Kirsch (5 patents)Wei ZhangWei Zhang (4 patents)Tian ChenTian Chen (1 patent)Guoyao XiaGuoyao Xia (1 patent)Tian ChenTian Chen (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Northwestern University (5 from 2,118 patents)

2. Cambria Pharmaceuticals, Inc. (4 from 4 patents)

3. Cambria Pharmaceuticals Distributing Trust (0 patent)


5 patents:

1. 10167263 - Treatment of amyotrophic lateral sclerosis

2. 9593069 - Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis

3. 9499494 - Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis

4. 9162968 - Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis

5. 8722939 - Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/19/2025
Loading…